Farmace, MB Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
5,936 |
- |
49 |
47 |
- |
0.01 |
33.21 |
37.69 |
0.79 |
47 |
1,561 |
0 |
1,608 |
2022 |
---|
119,288 |
- |
25,464 |
24,191 |
- |
0.20 |
0.10 |
45.46 |
20.28 |
24,238 |
2,393 |
0 |
26,631 |
2023 |
---|
160,552 |
- |
14,554 |
13,826 |
- |
0.24 |
0.19 |
40.82 |
8.61 |
38,064 |
7,134 |
0 |
45,198 |
Register and
explore Okredo data2023 |
---|
160,552 |
- |
14,554 |
13,826 |
- |
0.24 |
0.19 |
40.82 |
8.61 |
38,064 |
7,134 |
0 |
45,198 |
Register and
explore Okredo data2023
Turnover (€)
160,552 €35 % *
Sales per employee (€)
-Profit before tax (€)
14,554 €-43 % *
Net Profit (€)
13,826 €-43 % *
Profit per employee (€)
-Working capital requirement
0.24 20.00 % *
Debt-to-equity ratio
0.19 90.00 % *
Total profitability (%)
40.82 %-10.21 % *
Net profitability (%)
8.61 %-57.54 % *
Equity (€)
38,064 €57 % *
Amounts Payable And Liabilities (€)
7,134 €198 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
45,198 €70 % *